Bioactive factors in platelet-rich plasma obtained by apheresis

Transfusion Medicine and Hemotherapy

Volumn 40, Issue 6, 2013, Pages 432-440

  Krüger, Jan Philipp ^a   Freymann, Undine ^a   Vetterlein, Samuel ^a   Neumann, Katja ^a   Endres, Michaela ^a,b   Kaps, Christian ^a,b  

^a TRANSTISSUE TECHNOLOGIES GMBH   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Apheresis; Cartilage regeneration; Chondrogenesis; Growth factors; Platelet rich plasma

Indexed keywords

ACTIVIN A; ARTEMIN; BONE MORPHOGENETIC PROTEIN 15; BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEIN 4; BONE MORPHOGENETIC PROTEIN 5; BONE MORPHOGENETIC PROTEIN 6; BRAIN DERIVED NEUROTROPHIC FACTOR; CONNECTIVE TISSUE GROWTH FACTOR; EPIREGULIN; FIBROBLAST GROWTH FACTOR 10; FIBROBLAST GROWTH FACTOR 16; FIBROBLAST GROWTH FACTOR 18; FIBROBLAST GROWTH FACTOR 19; FIBROBLAST GROWTH FACTOR 2; FIBROBLAST GROWTH FACTOR 21; FIBROBLAST GROWTH FACTOR 23; FIBROBLAST GROWTH FACTOR 4; FIBROBLAST GROWTH FACTOR 6; FIBROBLAST GROWTH FACTOR 8; FIBROBLAST GROWTH FACTOR 9; GROWTH DIFFERENTIATION FACTOR 1; GROWTH DIFFERENTIATION FACTOR 10; GROWTH DIFFERENTIATION FACTOR 3; GROWTH FACTOR; KERATINOCYTE GROWTH FACTOR; MYELOPID; OSTEOGENIC PROTEIN 1; OSTEOGENIN; TRANSFORMING GROWTH FACTOR BETA3; CELL PROTEIN; CHEMOKINE; CILIARY NEUROTROPHIC FACTOR; FIBROBLAST GROWTH FACTOR; GROWTH DIFFERENTIATION FACTOR; GROWTH DIFFERENTIATION FACTOR 5; HEPARIN BINDING EPIDERMAL GROWTH FACTOR; INTERLEUKIN DERIVATIVE; MATRIX METALLOPROTEINASE; MEMBRANE PROTEIN; NEUROTROPHIN 3; PLATELET DERIVED GROWTH FACTOR AA; PLATELET DERIVED GROWTH FACTOR AB; RECEPTOR PROTEIN; TISSUE INHIBITOR OF METALLOPROTEINASE; TRANSFORMING GROWTH FACTOR ALPHA; TRANSFORMING GROWTH FACTOR BETA;

ADULT; AGED; ANALYTIC METHOD; APHERESIS; ARTICLE; BONE REMODELING; CARTILAGE; CARTILAGE MATRIX; CELL DIFFERENTIATION; CLINICAL ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; MIDDLE AGED; PROTEIN ANALYSIS; PROTEIN ANTIBODY MEMBRANE ARRAY; THROMBOCYTE RICH PLASMA; YOUNG ADULT; BIOCHEMICAL COMPOSITION; CELL MIGRATION; CHONDROGENESIS; GENETIC VARIABILITY; HUMAN CELL; HUMAN EXPERIMENT; NORMAL HUMAN; PLASMAPHERESIS; PROTEIN DETERMINATION; SIGNAL TRANSDUCTION; THROMBOCYTE ACTIVATION; TISSUE REPAIR;

EID: 84896497133     PISSN: 16603796     EISSN: 16603818     Source Type: Journal    
DOI: 10.1159/000356329     Document Type: Article

References (55)

1. Lucas-Samuel S: Advanced therapy: From European regulatory framework to national regulatory framework (in French). Transfus Clin Biol 2013; 20:221-224.
2. Langer R, Vacanti JP: Tissue engineering. Science 1993;260:920-926.
3. Brittberg M, Lindahl A, Nilsson A, Ohlsson C, Isaksson O, Peterson L: Treatment of deep cartilage defects in the knee with autologous chondrocyte transplantation. N Engl J Med 1994;331:889-895.
4. Endres M, Neumann K, Schroder SE, Vetterlein S, Morawietz L, Ringe J, Sittinger M, Kaps C: Human polymer-based cartilage grafts for the regeneration of articular cartilage defects. Tissue Cell 2007;39: 293-301.
5. Steadman JR, Rodkey WG, Briggs KK, Rodrigo JJ: The microfracture technic in the management of complete cartilage defects in the knee joint (in German). Orthopade 1999;28:26-32.
6. Patrascu JM, Freymann U, Kaps C, Poenaru DV: Repair of a post-traumatic cartilage defect with a cell-free polymer-based cartilage implant: a followup at two years by MRI and histological review. J Bone Joint Surg Br 2010;92:1160-1163.
7. Zantop T, Petersen W: Arthroscopic implantation of a matrix to cover large chondral defect during microfracture. Arthroscopy 2009;25:1354-1360.
8. Siclari A, Mascaro G, Gentili C, Kaps C, Cancedda R, Boux E: Cartilage repair in the knee with subchondral drilling augmented with a platelet-rich plasma-immersed polymer-based implant. Knee Surg Sports Traumatol Arthrosc 2013; DOI: 10.1007/s00167-013-2484-1.
9. Siclari A, Mascaro G, Gentili C, Cancedda R, Boux E: A cell-free scaffold-based cartilage repair provides improved function hyaline-like repair at one year. Clin Orthop Relat Res 2012;470:910-919.
10. Alsousou J, Thompson M, Hulley P, Noble A, Willett K: The biology of platelet-rich plasma and its application in trauma and orthopaedic surgery: a review of the literature. J Bone Joint Surg Br 2009; 91:987-996.
11. van der Meer PF: Platelet concentrates, from whole blood or collected by apheresis? Transfus Apher Sci 2013;48:129-131.
12. de Almeida AM, Demange MK, Sobrado MF, Rodrigues MB, Pedrinelli A, Hernandez AJ: Patellar tendon healing with platelet-rich plasma: a prospective randomized controlled trial. Am J Sports Med 2012;40:1282-1288.
13. Silva A, Sampaio R: Anatomic ACL reconstruction: does the platelet-rich plasma accelerate tendon healing? Knee Surg Sports Traumatol Arthrosc 2009;17:676-682.
14. Eskan MA, Greenwell H, Hill M, Morton D, Vidal R, Shumway B, Girouard ME: Platelet-rich plasma assisted guided bone regeneration for ridge augmentation: a randomized, controlled clinical trial. J Periodontol 2013; doi: 10.1902/jop.2013.130260.
15. Krüger JP, Hondke S, Endres M, Pruss A, Siclari A, Kaps C: Human platelet-rich plasma stimulates migration and chondrogenic differentiation of human subchondral progenitor cells. J Orthop Res 2012;30:845-852.
16. Knutsen G, Engebretsen L, Ludvigsen TC, Drogset JO, Grontvedt T, Solheim E, Strand T, Roberts S, Isaksen V, Johansen O: Autologous chondrocyte implantation compared with microfracture in the knee. A randomized trial. J Bone Joint Surg Am 2004;86A:455-464.
17. Gudas R, Kalesinskas RJ, Kimtys V, Stankevicius E, Toliusis V, Bernotavicius G, Smailys A: A prospective randomized clinical study of mosaic osteochondral autologous transplantation versus microfracture for the treatment of osteochondral defects in the knee joint in young athletes. Arthroscopy 2005;21:1066-1075.
18. Frisbie DD, Oxford JT, Southwood L, Trotter GW, Rodkey WG, Steadman JR, Goodnight JL, McIlwraith CW: Early events in cartilage repair after subchondral bone microfracture. Clin Orthop Relat Res 2003;(407):215-227.
19. Goldring MB, Tsuchimochi K, Ijiri K: The control of chondrogenesis. J Cell Biochem 2006;97:33-44.
20. Marx RE:Platelet-rich plasma (PRP): what is PRP and what is not PRP? Implant Dent 2001;10:225-228.
21. Nikolidakis D, Jansen JA: The biology of plateletrich plasma and its application in oral surgery: literature review. Tissue Eng Part B Rev 2008;14: 249-258.
22. Anitua E, Andia I, Ardanza B, Nurden P, Nurden AT: Autologous platelets as a source of proteins for healing and tissue regeneration. Thromb Haemost 2004;91:4-15.
23. Stewart AA, Byron CR, Pondenis H, Stewart MC: Effect of fibroblast growth factor-2 on equine mesenchymal stem cell monolayer expansion and chondrogenesis. Am J Vet Res 2007;68:941-945.
24. Barry F, Boynton RE, Liu B, Murphy JM: Chondrogenic differentiation of mesenchymal stem cells from bone marrow: differentiation-dependent gene expression of matrix components. Exp Cell Res 2001;268:189-200.
25. Longobardi L, O'Rear L, Aakula S, Johnstone B, Shimer K, Chytil A, Horton WA, Moses HL, Spagnoli A: Effect of IGF-I in the chondrogenesis of bone marrow mesenchymal stem cells in the presence or absence of TGF-beta signaling. J Bone Miner Res 2006;21:626-636.
26. Kon E, Buda R, Filardo G, Di Martino A, Timoncini A, Cenacchi A, Fornasari PM, Giannini S, Marcacci M: Platelet-rich plasma: intra-articular knee injections produced favorable results on degenerative cartilage lesions. Knee Surg Sports Traumatol Arthrosc 2010;18:472-479.
27. Weibrich G, Kleis WK, Hafner G, Hitzler WE: Growth factor levels in platelet-rich plasma and correlations with donor age, sex, and platelet count. J Craniomaxillofac Surg 2002;30:97-102.
28. Kaps C, Bramlage C, Smolian H, Haisch A, Ungethum U, Burmester GR, Sittinger M, Gross G, Haupl T: Bone morphogenetic proteins promote cartilage differentiation and protect engineered artificial cartilage from fibroblast invasion and destruction. Arthritis Rheum 2002;46:149-162.
29. Kon E, Filardo G, Matteo BD, Marcacci M: PRP for the treatment of cartilage pathology. Open Orthop J 2013;7:120-128.
30. Patel S, Dhillon MS, Aggarwal S, Marwaha N, Jain A. Treatment with platelet-rich plasma is more effective than placebo for knee osteoarthritis: a prospective, double-blind, randomized trial. Am J Sports Med 2013,41:356-364.
31. Amable PR, Carias RB, Teixeira MV, da Cruz Pacheco I, Correa do Amaral RJ, Granjeiro JM, Borojevic R. Platelet-rich plasma preparation for regenerative medicine: optimization and quantification of cytokines and growth factors. Stem Cell Res Ther 2013,4:67.
32. Krüger JP, Ketzmar AK, Endres M, Pruß A, Siclari A, Kaps C: Human platelet-rich plasma induces chondrogenic differentiation of subchondral progenitor cells in polyglycolic acid-hyaluronan scaffolds. J Orthop Res 2012;30:845-852.
33. Fiedler J, Roderer G, Gunther KP, Brenner RE: BMP-2, BMP-4, and PDGF-bb stimulate chemotactic migration of primary human mesenchymal progenitor cells. J Cell Biochem 2002;87:305-312.
34. Fiedler J, Brill C, Blum WF, Brenner RE: IGF-I and IGF-II stimulate directed cell migration of bone-marrow-derived human mesenchymal progenitor cells. Biochem Biophys Res Commun 2006; 345:1177-1183.
35. Mishima Y, Lotz M: Chemotaxis of human articular chondrocytes and mesenchymal stem cells. J Orthop Res 2008;26:1407-1412.
36. Gaissmaier C, Fritz J, Krackhardt T, Flesch I, Aicher WK, Ashammakhi N: Effect of human platelet supernatant on proliferation and matrix synthesis of human articular chondrocytes in monolayer and three-dimensional alginate cultures. Biomaterials 2005;26:1953-1960.
37. Tang QO, Shakib K, Heliotis M, Tsiridis E, Mantalaris A, Ripamonti U: TGF-beta3: a potential biological therapy for enhancing chondrogenesis. Expert Opin Biol Ther 2009;9:689-701.
38. van Beuningen HM, Glansbeek HL, van der Kraan PM, van den Berg WB: Differential effects of local application of BMP-2 or TGF-beta 1 on both articular cartilage composition and osteophyte formation. Osteoarthritis Cartilage 1998;6:306-317.
39. Schmitt B, Ringe J, Haupl T, Notter M, Manz R, Burmester GR, Sittinger M, Kaps C: BMP2 initiates chondrogenic lineage development of adult human mesenchymal stem cells in high-density culture. Differentiation 2003;71:567-577.
40. Jiang Y, Chen LK, Zhu DC, Zhang GR, Guo C, Qi YY, Ouyang HW: The inductive effect of bone morphogenetic protein-4 on chondral-lineage differentiation and in situ cartilage repair. Tissue Eng Part A 2010;16:1621-1632.
41. Steinert A, Weber M, Dimmler A, Julius C, Schutze N, Noth U, Cramer H, Eulert J, Zimmermann U, Hendrich C: Chondrogenic differentiation of mesenchymal progenitor cells encapsulated in ultrahigh-viscosity alginate. J Orthop Res 2003;21:1090-1097.
42. Hicks DL, Sage AB, Shelton E, Schumacher BL, Sah RL, Watson D:, Effect of bone morphogenetic proteins 2 and 7 on septal chondrocytes in alginate. Otolaryngol Head Neck Surg 2007;136:373-379.
43. Shen B, Wei A, Whittaker S, Williams LA, Tao H, Ma DD, Diwan AD: The role of BMP-7 in chondrogenic and osteogenic differentiation of human bone marrow multipotent mesenchymal stromal cells in vitro. J Cell Biochem 2010;109: 406-416.
44. Arnott JA, Lambi AG, Mundy C, Hendesi H, Pixley RA, Owen TA, Safadi FF, Popoff SN: The role of connective tissue growth factor (CTGF/CCN2) in skeletogenesis. Crit Rev Eukaryot Gene Expr 2011;21:43-69.
45. Ellman MB, An HS, Muddasani P, Im HJ: Biological impact of the fibroblast growth factor family on articular cartilage and intervertebral disc homeostasis. Gene 2008;420:82-89.
46. Chhabra A, Zijerdi D, Zhang J, Kline A, Balian G, Hurwitz S: BMP-14 deficiency inhibits long bone fracture healing: a biochemical, histologic, and radiographic assessment. J Orthop Trauma 2005;19:629-634.
47. Zhang B, Yang S, Sun Z, Zhang Y, Xia T, Xu W, Ye S: Human mesenchymal stem cells induced by growth differentiation factor 5: an improved self-assembly tissue engineering method for cartilage repair. Tissue Eng Part C Methods 2011;17:1189-1199.
48. Boehm AK, Seth M, Mayr KG, Fortier LA: Hsp90 mediates insulin-like growth factor 1 and interleukin-1beta signaling in an age-dependent manner in equine articular chondrocytes. Arthritis Rheum 2007;56:2335-2343.
49. Van Osch GJ, Van Der Veen SW, Burger EH, Verwoerd-Verhoef HL: Chondrogenic potential of in vitro multiplied rabbit perichondrium cells cultured in alginate beads in defined medium. Tissue Eng 2000;6:321-330.
50. Danisovic L, Varga I, Polak S: Growth factors and chondrogenic differentiation of mesenchymal stem cells. Tissue Cell 2012;44:69-73.
51. Weiss S, Hennig T, Bock R, Steck E, Richter W: Impact of growth factors and PTHrP on early and late chondrogenic differentiation of human mesenchymal stem cells. J Cell Physiol 2010;223:84-93.
52. Hutchison MR: BDNF alters ERK/p38 MAPK activity ratios to promote differentiation in growth plate chondrocytes. Mol Endocrinol 2012;26:1406-1416.
53. Krejci P, Krakow D, Mekikian PB, Wilcox WR: Fibroblast growth factors 1, 2, 17, and 19 are the predominant FGF ligands expressed in human fetal growth plate cartilage. Pediatr Res 2007;61:267-272.
54. Moore EE, Bendele AM, Thompson DL, Littau A, Waggie KS, Reardon B, Ellsworth JL: Fibroblast growth factor-18 stimulates chondrogenesis and cartilage repair in a rat model of injury-induced osteoarthritis. Osteoarthritis Cartilage 2005;13:623-631.
55. Mishra A, Tummala P, King A, Lee B, Kraus M, Tse V, Jacobs CR: Buffered platelet-rich plasma enhances mesenchymal stem cell proliferation and chondrogenic differentiation. Tissue Eng Part C Methods 2009;15:431-435.